Treatment of AIDS and HIV-related conditions.

With about 1 miIlion persons in the US infected with the human immunodeficiency virus (lilV), the inevitable impact of the epidemic on primary care was only a matter of time. That time has come. The majority of family physicians are now caring for patients infected with HN. Providing primary care for patients infected with lllV presents a great challenge. Our understanding of the immunology and pathology of and therapy for lllV infection continues to evolve rapidly. The number of possible opportunistic infections, malignancies, and other complications associated with lllV disease is enormous. Multidrug regimens for prophylaxis, acute care, and chronic suppression are usually required. Providing this complex medical treatment while remaining attentive to the social, psychological, and family components of care is the challenge we must meet. Fortunately, the management of lllV infection has standardized in the last few years. This "Current Report-lllV" updates treatment recommendations outlined in our earlier review article in JABFP.l Subsequent articles in the series have addressed new developments in managing lllV infection.2-9 A comprehensive review of the dermatologic manifestations of lllV infection supplements these articles. to